Snowball logo
logo
PLX_logo

Protalix BioTherapeutics, Inc

$2.48-$0.07Β  (2.75%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
38.3547.6465.4953.452.7480.62
COGS
16.3519.5922.9824.3227.5124.83
Gross Profit
2228.0542.5129.0825.2455.79
Operating Expenses & Income
Operating Income
(20.46)(13.01)10.463.917(5.5)23.29
Total Operating Expenses
42.4641.0632.0525.1630.7432.5
R&D Expenses
29.7329.3517.0912.9719.0519.88
Selling General & Admin Expenses
4.0213.5825.4640.7911.6813.93
Earnings from Continuing Operations
Interest Expense
(7.521)(2.529)(3.18)(1.062)(1.191)(1.25)
Interest Income
0.4011.1461.2861.2991.0831.423
Income Tax Expense
6.4030.530.2541.2220.9964.519
Net Income
Net Income
(27.58)(14.93)8.3122.932(6.604)18.95
Supplemental
EBIT
(20.06)(11.87)11.755.216(4.417)24.71
EBITDA
(18.94)(10.78)12.946.52(2.952)26.28
In millions of USD, except % and values per 1 share